+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase



Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase



Journal of Medicinal Chemistry 51(3): 439-448



Malaria, caused by Plasmodia parasites, has re-emerged as a major problem, imposing its fatal effects on human health, especially due to multidrug resistance. In Plasmodia, orotidine 5'-monophosphate decarboxylase (ODCase) is an essential enzyme for the de novo synthesis of uridine 5'-monophosphate. Impairing ODCase in these pathogens is a promising strategy to develop novel classes of therapeutics. Encouraged by our recent discovery that 6-iodo uridine is a potent inhibitor of P. falciparum, we investigated the structure-activity relationships of various C6 derivatives of UMP. 6-Cyano, 6-azido, 6-amino, 6-methyl, 6- N-methylamino, and 6- N, N-dimethylamino derivatives of uridine were evaluated against P. falciparum. The mononucleotides of 6-cyano, 6-azido, 6-amino, and 6-methyl uridine derivatives were studied as inhibitors of plasmodial ODCase. 6-Azidouridine 5'-monophosphate is a potent covalent inhibitor of P. falciparum ODCase. 6-Methyluridine exhibited weak antimalarial activity against P. falciparum 3D7 isolate. 6- N-Methylamino and 6- N, N-dimethylamino uridine derivatives exhibited moderate antimalarial activities.

(PDF emailed within 0-6 h: $19.90)

Accession: 021810510

Download citation: RISBibTeXText

PMID: 18189347

DOI: 10.1021/jm7010673


Related references

Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents. Journal of Medicinal Chemistry 52(6): 1648-1658, 2009

Novel interactions of fluorinated nucleotide derivatives targeting orotidine 5'-monophosphate decarboxylase. Journal of Medicinal Chemistry 54(8): 2891-2901, 2011

Isolation and characterization of the orotidine 5'-monophosphate decarboxylase domain of the multifunctional protein uridine 5'-monophosphate synthase. Journal of Biological Chemistry 260(16): 9443-9451, 1985

A nonradioactive high-performance liquid chromatographic microassay for uridine 5'-monophosphate synthase, orotate phosphoribosyltransferase, and orotidine 5'-monophosphate decarboxylase. Analytical Biochemistry 299(2): 162-168, 2001

Proton transfer from C-6 of uridine 5'-monophosphate catalyzed by orotidine 5'-monophosphate decarboxylase: formation and stability of a vinyl carbanion intermediate and the effect of a 5-fluoro substituent. Journal of the American Chemical Society 134(35): 14580-14594, 2013

Structural diversity and plasticity associated with nucleotides targeting orotidine monophosphate decarboxylase. Journal of Medicinal Chemistry 51(3): 432-438, 2008

The crystal structure and mechanism of orotidine 5'-monophosphate decarboxylase. Proceedings of the National Academy of Sciences of the United States of America 97(5): 2005-2010, 2000

Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum. Biochemistry 47(12): 3842-3854, 2008

Electrostatic stress in catalysis: structure and mechanism of the enzyme orotidine monophosphate decarboxylase. Proceedings of the National Academy of Sciences of the United States of America 97(5): 2017-2022, 2000

A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity. Journal of Medicinal Chemistry 50(5): 915-921, 2007

Crystal structure of 3-hexulose-6-phosphate synthase, a member of the orotidine 5'-monophosphate decarboxylase suprafamily. Proteins 78(16): 3488-3492, 2011

Conformational changes in orotidine 5'-monophosphate decarboxylase: a structure-based explanation for how the 5'-phosphate group activates the enzyme. Biochemistry 51(43): 8665-8678, 2013

Crystal structures of orotidine monophosphate decarboxylase: does the structure reveal the mechanism of nature's most proficient enzyme?. Chembiochem 2(2): 113-118, 2002

The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase. Journal of Biochemistry 152(2): 133-138, 2013

Indiscriminate binding by orotidine 5'-phosphate decarboxylase of uridine 5'-phosphate derivatives with bulky anionic c6 substituents. Biochemistry 46(46): 13331-13343, 2007